Bisopro 2.5 Plus 10pcs

Pharmacology of Bisopro 2.5 Plus Tablet

A medication called Bisopro 2.5 Plus is used to treat hypertension (high blood pressure). When one medication is ineffective in controlling blood pressure, Bisopro 2.5 Plus, a combination of two medications, can assist. It decreases the likelihood of future heart attacks and strokes.

Dosage & Administration of Bisopro 2.5 Plus Tablet

Hydrochlorothiazide is effective for treating hypertension in dosages of 12.5 to 50 mg, and bisoprolol is effective in once-daily readings of 2.5 to 40 mg. The antihypertensive effects increased with increasing dosages of either component in clinical studies of bisoprolol/hydrochlorothiazide combination therapy using bisoprolol measurements of 2.5 to 20 mg and hydrochlorothiazide dosages of 6.25 to 25 mg.

Introduction of Therapy: The lowest dose of this combination, one 2.5/6.25 mg tablet taken once daily, may be used to initiate antihypertensive therapy. This tablet may then be titrated (in 14-day intervals) up to the maximum recommended doses of 20/12.5 mg once a day, if necessary.

Replacement Therapy: The mixture may be used in place of the titrated person's component parts.

Interaction of Bisopro 2.5 Plus Tablet

When used together, these sedatives may enhance the effects of other concurrently used antihypertensive medications. Other beta-blocking agents should not be taken with this combination of medicine. Patients using catecholamine-depleting medications, such as guanethidine or reserpine, should be strictly monitored because the added beta-adrenergic blocking activity of bisoprolol fumarate may result in an excessive reduction in mental activity. When a patient is receiving clonidine and another medication at the same time, it is suggested that the other medication be stopped for a few days soon after the clonidine is stopped. When myocardial depressants or AV conduction inhibitors, such as some calcium antagonists (especially of the phenylethylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic specialists, such as disopyramide, are used concurrently, this combination medication should be used with caution. Beta-blockers and digitalis glycosides both reduce heart rate and moderate atrioventricular conduction. The risk of bradycardia can increase with concurrent use.

Contraindications

Patients who have cardiogenic shock, obvious cardiac disappointment, moment or third-degree AV square, checked sinus bradycardia, anuria, or sensitivity to either ingredient of this product or to other sulfonamide-derived medications should not use it.

Side Effects of Bisopro 2.5 Plus Tablet

• Nausea
• Constipation
• Fatigue
• Headache
• Diarrhea
• Dizziness
• Cold extremities
• Slow heart rate
• Increased blood uric acid
• Decreased potassium level in the blood
• Glucose intolerance
• Altered blood lipid level
• Decreased magnesium level in blood
• Increased calcium level in the blood

Pregnancy & Lactation

Utilize in Pregnancy: Pregnancy Category C. There are no satisfactory and well-controlled ponders in pregnant ladies. Bisoprolol Fumarate and Hydrochlorothiazide ought to be utilized amid pregnancy as it were on the off chance that the potential advantage legitimizes the hazard to the embryo.

Utilize in Nursing Moms: Bisoprolol Fumarate alone or in combination with Hydrochlorothiazide has not been examined in nursing moms. Thiazides are excreted in the human breast drain. Little sums of Bisoprolol Fumarate have been recognized within the drain of lactating rats. Since of the potential for genuine unfavorable responses in nursing newborn children, a choice ought to be made whether to suspend nursing or to discontinue the sedation, taking under consideration the significance of the medication to the mother.

Precautions & Warnings

• Certain people on thiazide diuretics may experience an accelerated onset of hyperuricemia or severe gout. 
• Dry mouth, thirst, lack of energy, dormancy, fatigue, eagerness, muscle cramps or spasms, extreme weakness, hypotension, oliguria, tachycardia, and gastrointestinal unsettling effects like vomiting and heaving are caution indicators or indications of fluid and electrolyte difficulty. 
• Hypokalemia might develop. If a withdrawal from this combination therapy is planned, it should be done gradually over the course of around two weeks. Patients need to be closely monitored.

Storage Conditions

Keep below 30°C temperature, absent from light & dampness. Keep out of the reach of children.